“…With some exceptions (Killeen et al, 2007; Knox, 1985; Kunkel et al, 2015; Lipsitch and Samore, 2002; Miller et al, 2016; Panagiotopoulos et al, 1999), the population-level benefit of interventions specifically designed to control the spread of infectious disease exceeds the sum of individual-level benefits; the paradigm examples are herd immunity from vaccine against communicable diseases (Fine, 1993) and contagion-reducing effects of treatment for infections like tuberculosis, HIV and other sexually transmitted infections, and malaria (Boily et al, 2012; Greenwood, 2010). However, the population-level benefit of interventions that utilize behavioral changes to control for sexually transmitted diseases, can be more complex (Kremer and Morcom, 1998).…”